Creating a robust research enterprise
More than two years ago, the Public Affairs Advisory Committee at the 91Ó°¿â and Molecular Biology began focusing time and effort on identifying systemic problems facing the scientific research community. Funding, or lack thereof, obviously has added considerable stress, but other issues also need to be addressed to optimize the effectiveness and sustainability of the biomedical research enterprise. We’ve written about these efforts in the “News from the Hill” columns in 91Ó°¿âToday, researched scholarly works by luminaries in the research community and published our findings in a . In addition, in February, the PAAC hosted a multiday summit to identify what the scientific community can do to improve itself and the future of the field that we love.
In the columns published in 91Ó°¿âToday and the Policy Blotter, the , we’ve shared with the community our thoughts and experiences regarding how best to ensure into the future a robust and sustained biomedical research enterprise. We’ve formed partnerships with organizations that have complementary interests, such as Rescuing Biomedical Research (now directed by former 91Ó°¿âpolicy analyst Christopher Pickett) and the Future of Research. We’ve identified a series of recommendations for improving the research enterprise that are specific and enjoy broad support within our community; we are taking actions to ensure that these recommendations are achieved.
In the following months, essays by different PAAC members and our partners will appear in 91Ó°¿âToday, describing the actions we’re promoting and explaining their underlying rationales. For example, we’ll discuss the importance of optimizing the roles of staff scientists in the future, the merits of standardizing postdoctoral positions, and the best approaches for defining what a sustainable enterprise looks like and setting research funding levels to achieve sustainability.
With these essays, our goal is to explain what we are doing and to open conversations with our colleagues. We acknowledge that many of the issues are complex and that we may disagree on the wisdom of specific steps or actions. However, we are confident that we all agree that the American biomedical research enterprise is so important that we must pursue activities that will help to sustain our field well into the future.
Enjoy reading 91Ó°¿âToday?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91Ó°¿âToday
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Policy
Policy highlights or most popular articles

Seven steps to advocating in your home state
Find out how to schedule, prepare for and conduct a productive district office meeting to communicate the importance of fundamental scientific research funding to your representatives.

91Ó°¿âmembers call for funding and agency support amidst uncertainty
In 60 meetings on Capitol Hill, scientists urge legislators to reaffirm support for scientific innovation

Embrace your neurodivergence and flourish in college
This guide offers practical advice on setting yourself up for success — learn how to leverage campus resources, work with professors and embrace your strengths.

91Ó°¿âhonors Lawrence Tabak with public service award
He will deliver prerecorded remarks at the 2025 91Ó°¿âAnnual Meeting in Chicago.

Summer internships in an unpredictable funding environment
With the National Institutes of Health and other institutions canceling summer programs, many students are left scrambling for alternatives. If your program has been canceled or delayed, consider applying for other opportunities or taking a course.

Black excellence in biotech: Shaping the future of an industry
This Black History Month, we highlight the impact of DEI initiatives, trailblazing scientists and industry leaders working to create a more inclusive and scientific community. Discover how you can be part of the movement.